Amphastar Pharmaceuticals (AMPH) PT Lowered to $21 at Piper Sandler
Tweet
Share
E-mailGet Alerts AMPH Hot Sheet
Price: $18.12 -1.79%
Rating Summary:
2 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
2 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Piper Sandler analyst David Amsellem lowered the price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $21.00 (from $25.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Tokio Marine Holdings, Inc (8766:JP) (TKOMY) PT Lowered to JPY8,400 at Nomura/Instinet
- Amphastar Pharmaceuticals (AMPH) PT Lowered to $20 at Barclays
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
